PMC:7291971 / 2438-2612
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T50","span":{"begin":42,"end":50},"obj":"SP_9"},{"id":"T51","span":{"begin":109,"end":119},"obj":"SP_7"},{"id":"T52","span":{"begin":164,"end":171},"obj":"NCBITaxon:10239"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"34","span":{"begin":42,"end":46},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":109,"end":117},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":23,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T15","span":{"begin":73,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T16","span":{"begin":164,"end":171},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}
2_test
{"project":"2_test","denotations":[{"id":"32563813-12730500-29105561","span":{"begin":28,"end":29},"obj":"12730500"},{"id":"32563813-27344959-29105562","span":{"begin":78,"end":79},"obj":"27344959"},{"id":"32563813-32015508-29105563","span":{"begin":122,"end":123},"obj":"32015508"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}
MyTest
{"project":"MyTest","denotations":[{"id":"32563813-12730500-29105561","span":{"begin":28,"end":29},"obj":"12730500"},{"id":"32563813-27344959-29105562","span":{"begin":78,"end":79},"obj":"27344959"},{"id":"32563813-32015508-29105563","span":{"begin":122,"end":123},"obj":"32015508"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":", case fatality rate ≈ 10% [2]), in 2012 (MERS-CoV, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. T"}